Recursion Pharmaceuticals, Inc. CEO Christopher Gibson completed a sale of company stock over two days, on August 7 and August 8, 2024. Gibson sold a total of 50,000 shares of Class A Common Stock in open market transactions. On the first day, 30,000 shares were sold at a price of $7.10 per share, followed by 20,000 shares at $6.50 per share the next day. The total market value of the disposed shares amounted to $343,000. Following these transactions, Gibson directly holds 758,738 shares of Recursion Pharmaceuticals.

Recursion Pharmaceuticals, Inc. CEO Christopher Gibson completed a sale of company stock over two days, on August 7 and August 8, 2024. Gibson sold a total of 50,000 shares of Class A Common Stock in open market transactions. On the first day, 30,000 shares were sold at a price of $7.10 per share, followed by 20,000 shares at $6.50 per share the next day. The total market value of the disposed shares amounted to $343,000. Following these transactions, Gibson directly holds 758,738 shares of Recursion Pharmaceuticals.